The transcript levels of the DNMT3A gene were significantly elevated, showing a two-fold increase in both blood (p = 0.001) and tissue samples (p = 0.001) of AD patients compared to the control group (Figure 1C). The gene discussed is DNMT3A; the disease is Alzheimer disease.